Dim Clínica Privada

Ramos Mejía, Buenos Aires B1704ETD

0 studies enrolling now · 7 studies all time

What they study most

Arthritis, Rheumatoid, Cardiovascular Diseases, Heart Failure With Preserved Ejection Fraction (HFpEF), Liver Cirrhosis, Biliary, Obesity, T2D, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) — Completed
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis — Stopped early
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis — Completed